These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 36230805)
1. Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer. Birknerova N; Mancikova V; Paul ED; Matyasovsky J; Cekan P; Palicka V; Parova H Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230805 [TBL] [Abstract][Full Text] [Related]
2. Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic? Patel A; Patel S; Patel P; Tanavde V Front Oncol; 2022; 12():828434. PubMed ID: 35387114 [TBL] [Abstract][Full Text] [Related]
3. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer. Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614 [TBL] [Abstract][Full Text] [Related]
4. Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation. Anderson CJ; Yang H; Parsons J; Ahrens WA; Jagosky MH; Hsu JH; Patt JC; Kneisl JS; Steuerwald NM Clin Orthop Relat Res; 2024 Jun; ():. PubMed ID: 38905450 [TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs. Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579 [TBL] [Abstract][Full Text] [Related]
6. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer. Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056 [TBL] [Abstract][Full Text] [Related]
7. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives. Cristaldi M; Mauceri R; Di Fede O; Giuliana G; Campisi G; Panzarella V Front Physiol; 2019; 10():1476. PubMed ID: 31920689 [TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges. Nonaka T; Wong DTW J Dent Res; 2018 Jun; 97(6):701-708. PubMed ID: 29513618 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma. Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301 [TBL] [Abstract][Full Text] [Related]
10. Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer. Liu W; Ji T; Zhang C; Zhou Q; Bao Z Oral Oncol; 2022 Nov; 134():106129. PubMed ID: 36202068 [TBL] [Abstract][Full Text] [Related]
11. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role. Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078 [TBL] [Abstract][Full Text] [Related]
12. Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology. Tan WY; Nagabhyrava S; Ang-Olson O; Das P; Ladel L; Sailo B; He L; Sharma A; Ahuja N Curr Issues Mol Biol; 2024 Jun; 46(7):6533-6565. PubMed ID: 39057032 [TBL] [Abstract][Full Text] [Related]
13. The Promise of Circulating Tumor DNA in Head and Neck Cancer. Aulakh SS; Silverman DA; Young K; Dennis SK; Birkeland AC Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740633 [TBL] [Abstract][Full Text] [Related]
14. Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma? Ghiyasimoghaddam N; Shayan N; Mirkatuli HA; Baghbani M; Ameli N; Ashari Z; Mohtasham N Discov Oncol; 2024 Sep; 15(1):427. PubMed ID: 39259454 [TBL] [Abstract][Full Text] [Related]
15. Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer. Wang R; Yang Y; Lu T; Cui Y; Li B; Liu X PeerJ; 2024; 12():e16802. PubMed ID: 38313016 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma. Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138 [TBL] [Abstract][Full Text] [Related]
17. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges. Seyhan AA Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215 [TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
19. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis. S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163 [TBL] [Abstract][Full Text] [Related]
20. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis. Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Santos MA; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34206840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]